These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1358260)

  • 1. Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.
    Mysliwietz J; Thierfelder S
    Blood; 1992 Nov; 80(10):2661-7. PubMed ID: 1358260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antilymphocytic antibodies and marrow transplantation. XIV. Antibody-induced suppression of graft-versus-host disease in C3-decomplemented mice differentiates two T-cell-depletion pathways.
    Thierfelder S; Mysliwietz J; Hoffmann-Fezer G; Kummer U
    Blood; 1991 May; 77(10):2285-91. PubMed ID: 2029584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR; Majewski D
    Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anti-CD3 monoclonal antibody on engraftment of T-cell-depleted bone marrow allografts in mice: host T-cell suppression, growth factors, and space.
    Hiruma K; Hirsch R; Patchen M; Bluestone JA; Gress RE
    Blood; 1992 Jun; 79(11):3050-8. PubMed ID: 1534027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed to T cells or their subsets. II. Differential effectiveness of IgG2a and IgG2b isotypes of anti-CD3 and anti-CD4 moAb.
    Knulst AC; Noort WA; Tibbe GJ; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Oct; 14(4):535-43. PubMed ID: 7858528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation?
    Simpson D
    BioDrugs; 2003; 17(3):147-54. PubMed ID: 12749751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilymphocytic antibodies and marrow transplantation. IX. T-cell depletion in marrow donors with C1q high and low affinity antibodies for suppression of GVHD in fully mismatched mice.
    Antica M; Hoffmann-Fezer G; Thierfelder S
    Exp Hematol; 1989 Oct; 17(9):942-7. PubMed ID: 2570711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the YCD3-1 anti-mouse monoclonal on murine GvHD.
    OKunewick JP; Kociban DL; Machen LL; Buffo MJ
    Cell Transplant; 1993; 2(4):331-7. PubMed ID: 8162275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilymphocytic antibodies and marrow transplantation. VIII. Recipient conditioning with Clq-affine monoclonal anti-pan T antibodies prevents GVHD in homozygous fully mismatched mice.
    Thierfelder S; Kummer U; Schuh R; Mysliwietz J
    Blood; 1986 Oct; 68(4):818-24. PubMed ID: 2875752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin.
    Vallera DA; Taylor PA; Panoskaltsis-Mortari A; Blazar BR
    Blood; 1995 Dec; 86(11):4367-75. PubMed ID: 7492798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.
    Anasetti C; Martin PJ; Storb R; Appelbaum FR; Beatty PG; Davis J; Doney K; Hill HF; Stewart P; Sullivan KM
    Transplantation; 1992 Nov; 54(5):844-51. PubMed ID: 1440852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
    Young KJ; DuTemple B; Phillips MJ; Zhang L
    J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased in vivo mitogenicity of anti-TCR/CD3 monoclonal antibody through reduced interaction with Fcgamma receptors.
    Kummer U; Zengerle U; Pischel J; Trautmann B; Mailhammer R; Sidell N
    Immunol Lett; 2001 Jan; 75(2):153-8. PubMed ID: 11137141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb.
    Liang Y; Huang T; Zhang C; Todorov I; Atkinson M; Kandeel F; Forman S; Zeng D
    Blood; 2005 Mar; 105(5):2180-8. PubMed ID: 15374883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody.
    Zhang C; Lou J; Li N; Todorov I; Lin CL; Cao YA; Contag CH; Kandeel F; Forman S; Zeng D
    J Immunol; 2007 Jan; 178(2):838-50. PubMed ID: 17202345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.